1. Home
  2. AYRO vs JAGX Comparison

AYRO vs JAGX Comparison

Compare AYRO & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYRO
  • JAGX
  • Stock Information
  • Founded
  • AYRO 2017
  • JAGX 2013
  • Country
  • AYRO United States
  • JAGX United States
  • Employees
  • AYRO N/A
  • JAGX N/A
  • Industry
  • AYRO Telecommunications Equipment
  • JAGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AYRO Consumer Discretionary
  • JAGX Health Care
  • Exchange
  • AYRO Nasdaq
  • JAGX Nasdaq
  • Market Cap
  • AYRO 4.1M
  • JAGX 3.8M
  • IPO Year
  • AYRO N/A
  • JAGX N/A
  • Fundamental
  • Price
  • AYRO $0.51
  • JAGX $9.10
  • Analyst Decision
  • AYRO
  • JAGX
  • Analyst Count
  • AYRO 0
  • JAGX 0
  • Target Price
  • AYRO N/A
  • JAGX N/A
  • AVG Volume (30 Days)
  • AYRO 144.1K
  • JAGX 66.3K
  • Earning Date
  • AYRO 05-14-2025
  • JAGX 05-13-2025
  • Dividend Yield
  • AYRO N/A
  • JAGX N/A
  • EPS Growth
  • AYRO N/A
  • JAGX N/A
  • EPS
  • AYRO N/A
  • JAGX N/A
  • Revenue
  • AYRO $63,777.00
  • JAGX $11,689,000.00
  • Revenue This Year
  • AYRO N/A
  • JAGX $38.22
  • Revenue Next Year
  • AYRO N/A
  • JAGX $39.96
  • P/E Ratio
  • AYRO N/A
  • JAGX N/A
  • Revenue Growth
  • AYRO N/A
  • JAGX 19.75
  • 52 Week Low
  • AYRO $0.38
  • JAGX $4.02
  • 52 Week High
  • AYRO $1.48
  • JAGX $540.00
  • Technical
  • Relative Strength Index (RSI)
  • AYRO 48.89
  • JAGX 63.91
  • Support Level
  • AYRO $0.48
  • JAGX $5.00
  • Resistance Level
  • AYRO $0.57
  • JAGX $6.13
  • Average True Range (ATR)
  • AYRO 0.06
  • JAGX 0.96
  • MACD
  • AYRO 0.01
  • JAGX 0.83
  • Stochastic Oscillator
  • AYRO 67.89
  • JAGX 89.53

About AYRO AYRO Inc.

AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: